FIBROGEN INC — Director's Dealing 2023

Jun 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-06-07

Reporting Person: Schoeneck James A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-07	Common Stock	A	8289	$0.00	Acquired	28766	Direct
2023-06-07	Common Stock	S	7100	$18.0264	Disposed	73722	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-07	Stock Option (Right to Buy)	$17.13	A	12666	Acquired	2033-06-06	Common Stock (12666)	Direct

Footnotes

F1: Represents the grant of restricted stock units that vest on the earlier of June 7, 2024 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.

F2: Represents the number of shares sold by the reporting person (pursuant to a 10b5-1 trading plan dated March 2, 2023) to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

F3: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $17.77 to $18.56. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: Options vest on the earlier of June 7, 2024 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.